Varicula Biotec
Business Services · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Willem-kolff-platz 1, Teterow, Mecklenbu...Phone Number
+49 3996159220233Website
www.varicula.deRevenue
$19.5 MillionIndustry
About Varicula Biotec
Is Varicula Biotec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Varicula Biotec is spiking on competitors!
Click to see if Varicula Biotec had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Varicula Biotec
Earning: See what the market has to say on Varicula Biotec recently announced quarterly report
Check if Varicula Biotec has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Varicula Biotec, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Varicula Biotec launches new products
Funding: Get notified immidiatlly once Varicula Biotec has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Varicula Biotec
Find 2 more new buyers
Company Profile Activity
Activity Insights
Varicula Biotec is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Varicula Biotec is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Varicula Biotec.
Varicula Biotec Tech Stack
A closer look at the technologies used by Varicula Biotec
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Varicula Biotec
Varicula Biotec GmbH is an innovative research company based in Wismar, specializing in the development and production of therapeutics based on BK-RiV. The company focuses on advancing immuno-oncological therapies through its strong immunomodulatory agent, BK-RiV, which is in the process of being developed into a human medicine. Varicula Biotec aim... Read More